```html

Vanishing Twin Syndrome

What is Vanishing Twin Syndrome?

Vanishing Twin Syndrome (VTS) refers to a phenomenon that occurs in early pregnancy when one of the embryos in a multiple‑gestation pregnancy (usually twins) dies and is reabsorbed, expelled, or otherwise disappears before the second trimester. Although the loss is often not felt by the mother, it can be detected on ultrasound when a second gestational sac or fetal pole is observed early on and then later appears to be absent.

VTS is most commonly identified during routine prenatal ultrasounds performed around 6‑10 weeks gestation. The remaining fetus usually continues to develop normally, but the syndrome may be associated with a slightly increased risk of certain complications such as preterm birth, low birth weight, or placental abnormalities.

Sources: Mayo Clinic; American College of Obstetricians and Gynecologists (ACOG); National Institutes of Health (NIH).

Common Causes

Vanishing Twin Syndrome is not usually caused by a single “disease,” but rather by a combination of biological, environmental, and maternal factors that affect early embryonic development. The most frequently cited contributors include:

• Chromosomal abnormalities: Aneuploidy (extra or missing chromosomes) in one embryo is the leading cause of early loss.
• Unequal implantation timing: One embryo may implant later, making it less viable.
Maternal age: Advanced maternal age (≥35) increases the risk of chromosomal errors.
• Uterine environment: Limited space or poor blood flow may favor one embryo over the other.
• Hormonal imbalances: Low progesterone or abnormal hCG patterns can impair early growth.
• Infections: Early viral (e.g., cytomegalovirus, rubella) or bacterial infections can damage a developing embryo.
• Maternal lifestyle factors: Smoking, excessive caffeine, alcohol, or illicit drug use raise the risk of early embryonic loss.
• Assisted reproductive technologies (ART): Higher-order pregnancies created through IVF often experience VTS because of crowding.
• Structural uterine anomalies: Fibroids, septate uterus, or incompetent cervix can compromise one gestational sac.
• Trauma: Significant abdominal trauma in the first trimester may disrupt implantation.

Associated Symptoms

Because VTS usually occurs before many pregnancy symptoms appear, many women do not notice any changes. When symptoms do arise, they are often non‑specific and overlap with normal early‑pregnancy experiences:

• Mild abdominal cramping or “twinges” (often confused with normal uterine growth)
• Light spotting or brown‑colored discharge (sub‑clinical bleeding)
• Sudden decrease in pregnancy‑related nausea or breast tenderness—especially if the mother reported a rapid “drop” in early symptoms
• Transient low‑grade fever if an infection contributed to the loss
• Feeling of “something missing” when an early ultrasound shows one sac but a later scan shows only one

Most of these signs are subtle, and many women never realize a twin was present unless an early scan was performed.

When to See a Doctor

While VTS is often self‑limiting, certain warning signs merit prompt medical attention:

• Heavy vaginal bleeding (soaking a pad in < 1 hour) or passing clots.
• Severe abdominal or pelvic pain that does not improve with rest.
• Fever >100.4°F (38°C) lasting more than 24 hours.
• Foul‑smelling vaginal discharge, suggestive of infection.
• Sudden loss of fetal movement after the first trimester (though rare in VTS).
• Any concern that a previously identified twin is no longer visible on a follow‑up ultrasound.

If any of these occur, contact your obstetrician, midwife, or go to the nearest emergency department.

Diagnosis

Diagnosing Vanishing Twin Syndrome relies heavily on imaging and careful clinical follow‑up:

1. Early Ultrasound (Transvaginal)

• Performed at 6–10 weeks gestation.
• Shows two gestational sacs, fetal poles, or cardiac activity in both embryos.
• Subsequent scan (usually 2–4 weeks later) reveals only one viable fetus.

2. Serial hCG Monitoring

• hCG levels rise rapidly in a healthy early pregnancy. A plateau or decline may hint at embryonic loss.
• Does not differentiate VTS from a single‑embryo miscarriage, but combined with ultrasound, it clarifies the picture.

3. Maternal Blood Tests

• Complete blood count (CBC) to rule out infection or anemia.
• Thyroid panel, progesterone, and other hormone levels when endocrine issues are suspected.

4. Review of Medical History & Lifestyle

• Assessment of ART cycles, medication use, substance exposure, and prior pregnancy outcomes.

5. Pathological Examination (Rare)

• If tissue is expelled vaginally, it can be sent for pathology to confirm fetal tissue.

Overall, the diagnosis is usually straightforward once serial ultrasounds show the disappearance of one gestational sac.

Treatment Options

There is no specific “cure” for VTS because it is the natural resolution of a non‑viable embryo. Management focuses on supporting the remaining pregnancy and addressing any complications.

Medical Management

• Follow‑up Ultrasound Surveillance: Repeat scans every 2–4 weeks to ensure the surviving fetus continues to grow appropriately.
• Progesterone Supplementation: May be prescribed if the mother has a documented deficiency or a history of recurrent loss.
• Antibiotics: Indicated only if there is evidence of infection (e.g., fever, foul discharge).
• Cervical Length Monitoring: In cases with a short cervix, a cerclage or progesterone may be considered to reduce preterm‑birth risk.

Home & Lifestyle Support

• Maintain a balanced diet rich in folic acid, iron, calcium, and omega‑3 fatty acids.
• Stay well‑hydrated and engage in moderate, pregnancy‑safe exercise (e.g., walking, prenatal yoga).
• Avoid smoking, alcohol, recreational drugs, and excessive caffeine.
• Take prenatal vitamins as recommended by your provider.
• Practice good hand hygiene and avoid exposure to known infections (e.g., avoid handling cat litter if not immunized against toxoplasmosis).

Prevention Tips

While it is impossible to prevent all cases of VTS—especially those due to random chromosomal errors—certain strategies can lower the overall risk of early embryonic loss:

• Preconception Health Check: Optimize weight, manage chronic conditions (diabetes, hypertension), and update vaccinations (influenza, pertussis, COVID‑19).
• Folic Acid Supplementation: 400–800 µg daily, starting at least 1 month before conception.
• Limit ART Cycle Size: When undergoing IVF, discuss elective single‑embryo transfer with your specialist to reduce the chance of multiple gestations.
• Smoking Cessation & Alcohol Moderation: Both significantly increase early loss rates.
• Stress Management: Chronic stress may affect hormone balance; incorporate relaxation techniques.
• Screen for Infections: Early testing for TORCH infections (Toxoplasma, Others, Rubella, Cytomegalovirus, Herpes) when planning pregnancy.
• Regular Prenatal Care: Early and consistent prenatal visits allow prompt detection of any abnormalities.

Emergency Warning Signs

Key Takeaways

Vanishing Twin Syndrome is a relatively common early‑pregnancy event, especially in pregnancies conceived via assisted reproductive technologies. Most women who experience VTS go on to have a healthy singleton pregnancy. Early ultrasound detection, routine prenatal care, and prompt attention to warning signs are essential to ensure the well‑being of both mother and the surviving fetus.

Always discuss any concerns with your obstetrician or midwife, and remember that while VTS can be emotionally distressing, it does not usually indicate a problem with the remaining pregnancy.

References:

• Mayo Clinic. “Vanishing twin syndrome.” Accessed June 2026.
• American College of Obstetricians and Gynecologists. “Multiple Pregnancy.” ACOG Practice Bulletin, 2023.
• National Institutes of Health. “Early Pregnancy Loss.” NIH Fact Sheet, 2022.
• Cleveland Clinic. “Twin Pregnancy: Risks & Management.” 2024.
• World Health Organization. “Guidelines for Prenatal Care.” WHO, 2023.

```